• METABASIS THERAPEUTICS INC Financial Overview

  • Income Statement: MBRX

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 9.02 M 4.39 M 4.63 M 51.37%
    Gross Profit -31.90 M -25.92 M -5.98 M 18.74%
    Net Income Before Extra Items/Preferred Div -41.80 M -33.27 M -8.53 M 20.41%
    Operating Income -44.34 M -36.81 M -7.53 M 16.98%
  • Cash Flow: MBRX

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing 896,000.00 40.59 M -39.70 M -4,430.58%
    Net Cash Flow - Investing -37.58 M 33.80 M -71.38 M 189.96%
    Net Cash Flow/Operating Activities -36.38 M -27.34 M -9.05 M 24.87%
  • Balance Sheet: MBRX

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 50.12 M 85.86 M -35.73 M -71.29%
    Total Liabilities 18.02 M 17.72 M 305,000.00 1.69%
    Shareholders Equity 32.10 M 68.14 M -36.04 M -112.26%
  • Key Ratios / Statistics: MBRX

    • Valuation

      Price/Earnings (TTM) -2.18
      Price/Sales (TTM) 10.14
      Price/Book (MRQ) 2.58
      Price/Cash Flow (TTM) -0.94
    • Profitability

      Gross Margin -353.65
      Operating Margin -491.61
      Profit Margin -463.45
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 3.69
      Current Ratio (MRQ) 3.74
      Long Term Debt-to-Equity (MRQ) 31.64
    • Management Effectiveness

      Return on Equity (TTM) -83.58
      Return on Assets (TTM) -78.95
      Return on Investments (TTM) -74.00